24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ichilov Medical Center
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:08
U.S. export crackdown triggers $5.5B hit for Nvidia, rattles ASML forecasts
09:17
The man who sold Mellanox to Nvidia now fears Israel is losing its edge
08:53
Full list of Israeli high-tech funding rounds in 2025
08:51
Brandlight raises $5.75M to help brands win the AI search arms race
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
3
Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay
4
Armis president sets bold goal: $1B in sales in three years, IPO in two
5
Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard
More news
Ichilov Medical Center
2 stories about Ichilov Medical Center
"The genome project will change the face of medicine in Israel and save human lives"
10.11.24
|
Roni Dori
Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information."
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov